Semax

Semax is a drug that was originally developed in Russia, and is primarily used in the treatment of stroke, cognitive disorders, and peptic ulcers. It is a heptapeptide, meaning it is composed of seven amino acids, and is derived from the adrenocorticotropic hormone (ACTH).

History

Semax was first developed in the late 20th century by the Institute of Molecular Genetics of the Russian Academy of Sciences. It was initially used in the treatment of stroke and cognitive disorders, but has since been found to have a wide range of potential applications.

Mechanism of action

Semax works by stimulating the release of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) in the brain. These substances are crucial for the survival and growth of neurons, and their release can lead to improved cognitive function and memory.

Uses

Semax is primarily used in the treatment of stroke and cognitive disorders. It has also been found to be effective in the treatment of peptic ulcers, and is currently being investigated for potential use in the treatment of Alzheimer's disease and Parkinson's disease.

Side effects

The most common side effects of Semax include nausea, headache, and insomnia. In rare cases, it can cause hypertension and tachycardia.

Legal status

In Russia, Semax is approved for medical use and is available by prescription. In the United States, it is not approved by the Food and Drug Administration (FDA), but can be legally imported for personal use.

See also

• Nootropic
• Cognitive enhancer
• Neurotrophic factor

Semax Resources
Latest articles Most recent articles Ongoing trials	Wikipedia